Insulet | PODD - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
Align Technology USD 0 0 2024-12
AtriCure USD 61M 0 2026-06
Baxter International USD 8.62B 6M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Boston Scientific USD 10.86B 148M 2026-03
Cardinal Health USD 7B 1.24B 2026-06
Cooper Companies USD 1.92B 54.8M 2026-06
Dexcom USD 1.3B 200K 2026-06
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Globus Medical USD 398K 38K 2026-03
ICU Medical USD 1.21B 49.38M 2026-06
Inogen USD 0 0 2022-06
Insulet USD 929.5M 0 2026-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
J&J USD 37.34B 183M 2026-06
Medtronic USD 25.62B 502M 2026-06
Merit Medical Systems USD 736.26M 1.1M 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Solventum Corp USD 4.57B 2M 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 809K 2026-06
Teleflex USD 2.72B 206.24M 2026-06
West Pharmaceutical Services USD 202.9M 100K 2026-06
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06